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Transdermal drug delivery is impeded by the natural barrier
of epidermis known as stratum corneum. This limits the route
to transport of drugs with a log octanol–water partition coef-
ficient of 1 to 3, molecular weight of less than 500 Da and
melting point of less than 200 °C. Nanotechnology has re-
ceived a widespread investigation as the nanocarriers are able
to fluidize the stratum corneum as a function of size, shape,
surface charges, and hydrophilicity–hydrophobicity balance,
while delivering drugs across the skin barrier. This presenta-
tion provides an overview on the transdermal drug delivery
performances of liposomes, ethosomes, transfersomes,
niosomes, magnetosomes, oil-in-water nanoemulsions, water-
in-oil nanoemulsions, bicontinuous nanoemulsions, covalently
crosslinked polysaccharide nanoparticles, ionically cross-
linked polysaccharide nanoparticles, polyelectrolyte coacervated
nanoparticles and hydrophobically modified polysaccharide
nanoparticles with respect to their ability to fuse or fluidize
lipid/protein/tight junction regimes of skin. Universal rela-
tionships of nanocarrier size, zeta potential and chemical
composition on transdermal permeation characteristics of drugs
will be discussed [1].
In recent years, the microwave is found to be able to exert
spacing of lipid architecture of stratum corneum into struc-
tureless domains and promote transdermal drug delivery [2,3].
It is able to act as a radiation permeation enhancer and work
synergistically with the chemical permeation enhancer such
as oleic acid to promote transdermal drug delivery. The per-
formance of microwave as transdermal permeation enhancer
is challenged by the type of dosage form applied on skin, where
the recent findings indicate that polymeric macromolecules
from semisolid samples can act as a binder to the intercellu-
lar spaces created by microwave, thereby leading to reduced
drug permeation.The presentation will highlight the latest find-
ings of microwave enabling transdermal nanocarrier and drug
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delivery. Microwave is reckoned to be the next generation tech-
nology in transdermal delivery. More research and development
works are required to examine its worth in drug delivery with
respect to the advances of nanotechnology and biologics.
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